{
    "organizations": [],
    "uuid": "3cb2f4be6300268130dd0043e16d92d02d702d98",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-dechra-pharmaceuticals-says-hy-rev/brief-dechra-pharmaceuticals-says-hy-revenue-up-11-pct-idUSFWN1QG02N",
    "ord_in_thread": 0,
    "title": "BRIEF-Dechra Pharmaceuticals Says HY Revenue Up 11 Pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 26 (Reuters) - Dechra Pharmaceuticals Plc:\n* SAYS REPORTED GROUP REVENUE FOR SIX MONTHS ENDED 31 DECEMBER 2017 INCREASED BY 11.2% AT CONSTANT EXCHANGE RATE\n* SAYS EUROPEAN PHARMACEUTICALS REVENUE GROWTH WAS 5.8% AT CONSTANT EXCHANGE RATE FOR SIX MONTHS ENDED 31 DECEMBER 2017\n* DECHRA PHARMACEUTICALS - NORTH AMERICAN PHARMACEUTICALS REVENUE GROWTH WAS 20.7% AT CONSTANT EXCHANGE RATE FOR SIX MONTHS ENDED 31 DECEMBER 2017\n* DECHRA PHARMACEUTICALS - ‍HY UNDERLYING OPERATING PROFIT GROWTH OF 22.3% AT CER (22.6% AT AER) WITH OPERATING MARGIN EXPANSION OF 220 BPS TO 24.6%​\n* ‍HY UNDERLYING DILUTED EPS GROWTH OF 19.8% TO 37.58 PENCE​\n* HY ‍UNDERLYING PROFIT BEFORE TAXATION INCREASED BY 17.6% AT CER TO £44.3 MILLION​\n* ‍DECLARE AN INTERIM DIVIDEND OF 7.33 PENCE PER SHARE​ * ‍CURRENT TRADING CONTINUES IN LINE WITH MANAGEMENT EXPECTATIONS​ Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-02-26T15:32:00.000+02:00",
    "crawled": "2018-02-27T15:09:16.020+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "dechra",
        "pharmaceutical",
        "plc",
        "say",
        "reported",
        "group",
        "revenue",
        "six",
        "month",
        "ended",
        "december",
        "increased",
        "constant",
        "exchange",
        "rate",
        "say",
        "european",
        "pharmaceutical",
        "revenue",
        "growth",
        "constant",
        "exchange",
        "rate",
        "six",
        "month",
        "ended",
        "december",
        "dechra",
        "pharmaceutical",
        "north",
        "american",
        "pharmaceutical",
        "revenue",
        "growth",
        "constant",
        "exchange",
        "rate",
        "six",
        "month",
        "ended",
        "december",
        "dechra",
        "pharmaceutical",
        "underlying",
        "operating",
        "profit",
        "growth",
        "cer",
        "aer",
        "operating",
        "margin",
        "expansion",
        "bps",
        "underlying",
        "diluted",
        "eps",
        "growth",
        "hy",
        "profit",
        "taxation",
        "increased",
        "cer",
        "interim",
        "dividend",
        "penny",
        "per",
        "trading",
        "continues",
        "line",
        "management",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}